Adherence; Antiretroviral therapy; Compliance; HAART; HIV
Indexed keywords
ANTIRETROVIRUS AGENT;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
DRUG EFFECT;
DRUG INDICATION;
DRUG RESPONSE;
DRUG USE;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAJOR CLINICAL STUDY;
MALE;
PATIENT COMPLIANCE;
PRESCRIPTION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
COHORT STUDIES;
CROSS-SECTIONAL STUDIES;
DRUG THERAPY, COMBINATION;
DRUG UTILIZATION;
EDUCATION;
FEMALE;
GUIDELINE ADHERENCE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
MALE;
PATIENT COMPLIANCE;
PHYSICIAN'S PRACTICE PATTERNS;
PRESCRIPTIONS, DRUG;
REVERSE TRANSCRIPTASE INHIBITORS;
RISK FACTORS;
SUBSTANCE ABUSE, INTRAVENOUS;
SWITZERLAND;
TREATMENT REFUSAL;
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS society-USA panel
Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 1997;277: 1962-9.
Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mortal Wkly Rep 1998;47(No. RR-5):1-83.
Kommission für Aids-Fragen. Neue empfehlungen zur behandlung der HIV-infektion bei erwachsenen
Subkommission Klinik der Eidg. Kommission für Aids-Fragen. Neue Empfehlungen zur Behandlung der HIV-Infektion bei Erwachsenen. Bull Bundesamts Gesundheit 1997;20:9-10.
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The advanced HIV disease ritonavir study group
Cameron DW, Heath-Chiozzi M, Danner S, et al. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet 1998; 351:543-9
Die schweizerische HIV-kohortenstudie - Verbindung zwischen klinischer forschung und ärztlicher Praxis
Opravil M, Rickenbach M, Ledergerber B. Die Schweizerische HIV-Kohortenstudie - Verbindung zwischen klinischer Forschung und ärztlicher Praxis. Therapeutische Umschau 1998;55:329-34.
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-15.
Predictors for not currently receiving protease inhibitor therapy: Results from a multisite interview project
Geneva, Switzerland
Nakashima AK, Jones JL, Burgess DA, Ward JW. Predictors for not currently receiving protease inhibitor therapy: results from a multisite interview project. XII World AIDS Conference, 1998, Geneva, Switzerland.
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: Implications for secondary prevention efforts
Stall R, Hoff C, Coates TJ, et al. Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:151-60.
Rethinking nonadherence: Historical perspectives on triple-drug therapy for HIV disease
Lerner BH, Gulick RM, Dubler NN. Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Ann Intern Med 1998;129:573-8.
